UBS Group AG - NEUROONE MED TECHNOLOGIES CO ownership

NEUROONE MED TECHNOLOGIES CO's ticker is NMTC and the CUSIP is 64130M209. A total of 11 filers reported holding NEUROONE MED TECHNOLOGIES CO in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of NEUROONE MED TECHNOLOGIES CO
ValueSharesWeighting
Q3 2023$96
-26.2%
1080.0%0.00%
Q2 2023$130
-25.3%
1080.0%0.00%
Q1 2023$174
-87.9%
108
-91.0%
0.00%
Q4 2022$1,438
+43.8%
1,198
+36.0%
0.00%
Q2 2022$1,0008810.00%
Other shareholders
NEUROONE MED TECHNOLOGIES CO shareholders Q2 2022
NameSharesValueWeighting ↓
Mayo Clinic 181,754$161,8340.31%
PERKINS CAPITAL MANAGEMENT INC 150,000$1340.13%
Nantahala Capital Management 1,250,000$1,113,0000.10%
Princeton Global Asset Management LLC 16,833$14,9880.00%
MAI Capital Management 50,000$44,5200.00%
SG Americas Securities, LLC 50,453$450.00%
Walleye Capital LLC 225,956$201,1910.00%
UBS Group AG 108$960.00%
NewEdge Advisors, LLC 2,380$2,1190.00%
OSAIC HOLDINGS, INC. 700$6230.00%
View complete list of NEUROONE MED TECHNOLOGIES CO shareholders